Cargando…

Pneumocystis pneumonia associated with human immunodeficiency virus infection without elevated (1 → 3)-β-D glucan: A case report

Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii is one of the most common opportunistic infections in immunosuppressed patients, particularly in patients with acquired immunodeficiency syndrome (AIDS). (1 → 3)-β-D-glucan is a component of the cell wall of P. jirovecii and other fungi s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamada, Takahiro, Furuta, Kenjiro, Tomioka, Hiromi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901181/ https://www.ncbi.nlm.nih.gov/pubmed/27330956 http://dx.doi.org/10.1016/j.rmcr.2016.04.005

Ejemplares similares

Pneumocystis pneumonia diagnosed by repeated measurements of β-D-glucan levels
por: Kawasaki, Yasutaka, et al.
Publicado: (2023)

Usefulness of ß-d-Glucan Assay for the First-Line Diagnosis of Pneumocystis Pneumonia and for Discriminating between Pneumocystis Colonization and Pneumocystis Pneumonia
por: Bigot, Jeanne, et al.
Publicado: (2022)

Diagnostic Performance of Bronchoalveolar Lavage (1,3)-β-d-Glucan Assay for Pneumocystis jirovecii Pneumonia
por: Zhou, Shiwei, et al.
Publicado: (2020)

Diagnostic Accuracy of (1→3)-β-D-glucan to Predict Pneumocystis Jirovecii Pneumonia in Non-HIV-infected Patients
por: Rogina, Petra, et al.
Publicado: (2020)

Pneumocystis Pneumonia Mimicking Atypical Pneumonia in a Patient With Human Immunodeficiency Virus Infection
por: Hashimoto, Takehiro, et al.
Publicado: (2022)

Prognostic significance of crazy paving ground grass opacities in non-HIV Pneumocystis jirovecii pneumonia: an observational cohort study
por: Kumagai, Shogo, et al.
Publicado: (2019)

Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study
por: Hammarström, Helena, et al.
Publicado: (2019)

Pneumocystis jirovecii Pneumonia and Human Immunodeficiency Virus Co-Infection in Western Iran
por: BOZORGOMID, Arezoo, et al.
Publicado: (2019)

Targeting β-glucans, vital components of the Pneumocystis cell wall
por: Wang, Mengyan, et al.
Publicado: (2023)

Clinical Performance of BAL Metagenomic Next-Generation Sequence and Serum (1,3)-β-D-Glucan for Differential Diagnosis of Pneumocystis jirovecii Pneumonia and Pneumocystis jirovecii Colonisation
por: Liu, Li, et al.
Publicado: (2021)

Prognostic implication of bronchoalveolar lavage fluid analysis in patients with Pneumocystis jirovecii pneumonia without human immunodeficiency virus infection
por: Chung, Chiwook, et al.
Publicado: (2022)

Acute eosinophilic pneumonia following heat‐not‐burn cigarette smoking
por: Kamada, Takahiro, et al.
Publicado: (2016)

1510. Evaluation of Quantitative (1,3)-β-D-glucan in Prediction of Pneumocystis jirovecii Pneumonia in Patients Living with HIV in New York
por: Yune, Philip, et al.
Publicado: (2023)

Lethal exacerbation of Pneumocystis carinii pneumonia in severe combined immunodeficiency mice after infection by pneumonia virus of mice
Publicado: (1993)

Pneumocystis Pneumonia in Human Immunodeficiency Virus–infected Adults and Adolescents: Current Concepts and Future Directions
por: Tasaka, Sadatomo
Publicado: (2015)

Trends in the Epidemiology and Outcomes of Pneumocystis Pneumonia among Human Immunodeficiency Virus (HIV) Hospitalizations
por: Elango, Kalaimani, et al.
Publicado: (2022)

Diagnostic accuracy of the 1,3-beta-d-glucan test and lactate dehydrogenase for pneumocystis pneumonia in non-HIV patients
por: Sun, Ruixue, et al.
Publicado: (2021)

A Negative (1,3)-β-D-Glucan Result Alone Is Not Sufficient to Rule Out a Diagnosis of Pneumocystis Pneumonia in Patients With Hematological Malignancies
por: Damiani, Céline, et al.
Publicado: (2021)

Incidence of Pneumocystis Pneumonia in Immunocompromised Patients without Human Immunodeficiency Virus on Intravenous Pentamidine Prophylaxis: A Systematic Review and Meta-Analysis
por: Chiu, Chia-Yu, et al.
Publicado: (2023)

Late Onset Combined Immunodeficiency Presenting with Recurrent Pneumocystis jiroveci Pneumonia
por: Papakonstantinou, Ilias, et al.
Publicado: (2014)

Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases
por: Kageyama, Takahiro, et al.
Publicado: (2019)

Elevated serum β-d-glucan levels in cavitary pulmonary nocardiosis
por: Yagyu, Kyoko, et al.
Publicado: (2020)

Case Report: Pneumonia in a Patient With Combined Variable Immunodeficiency: COVID-19 or Pneumocystis Pneumonia?
por: Tehrani, Shabnam, et al.
Publicado: (2022)

Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France
por: Roux, Antoine, et al.
Publicado: (2014)

Absence of Pneumocystis jirovecii Colonization in Human Immunodeficiency Virus-Infected Individuals With and Without Airway Obstruction and With Undetectable Viral Load
por: Ronit, Andreas, et al.
Publicado: (2016)

Pneumocystis Jiroveci Pneumonia and Newly Diagnosed Human Immunodeficiency Virus (AIDS) in a 63-Year-Old Woman
por: Sabbagh, Wissam, et al.
Publicado: (2018)

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients
por: Ibrahim, Atif, et al.
Publicado: (2023)

Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR
por: Huang, Yuan, et al.
Publicado: (2023)

Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
por: Xue, Ting, et al.
Publicado: (2023)

Clinical and translational research in Pneumocystis and Pneumocystis pneumonia
por: Huang, L.
Publicado: (2011)

Efficacy and safety of trimethoprim-sulfamethoxazole for the prevention of pneumocystis pneumonia in human immunodeficiency virus-negative immunodeficient patients: A systematic review and meta-analysis
por: Li, Rui, et al.
Publicado: (2021)

Treatment of Pneumocystis jirovecii pneumonia in non-human immunodeficiency virus-infected patients using a combination of trimethoprim-sulfamethoxazole and caspofungin
por: Wu, Huan-Huan, et al.
Publicado: (2022)

Circulating β-d-Glucan as a Marker of Subclinical Coronary Plaque in Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus
por: Isnard, Stéphane, et al.
Publicado: (2021)

Varicella‐zoster virus pneumonia co‐infected with Pneumocystis jirovecii
por: Zhang, Qianwen, et al.
Publicado: (2022)

Pneumocystis jiroveci Pneumonia
por: Haque, Abida K., et al.
Publicado: (2008)

Co-infection of Mycobacterium tuberculosis and Pneumocystis jirovecii in the Iranian Patients With Human Immunodeficiency Virus
por: Sheikholeslami, Maryam Fatemeh, et al.
Publicado: (2015)

Programmed death ligand 1 is overexpressed by neutrophils in the blood of immunocompromised human immunodeficiency virus-negative patients with Pneumocystis jirovecii pneumonia
por: Zhang, Nan-Nan, et al.
Publicado: (2019)

Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE
por: Atkinson, Andrew, et al.
Publicado: (2020)

Low cut-off value of serum (1,3)-beta-d-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study
por: Taniguchi, Jumpei, et al.
Publicado: (2021)

Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study
por: Kamada, Takahiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d2662ffe0to7t85dc0bkmot61i